We are pleased to announce the release of the second edition of the BioMeld Newsletter, highlighting the latest progress across the project and the advances achieved by our consortium partners. This edition also provides an overview of the path forward as we move toward the final phase of the project, with a growing focus on integration, validation, and translation of results.
In addition, the newsletter introduces the key exploitable outcomes emerging from BioMeld, outlining their potential for future medical and technological applications.
You can find the full version of the Newsletter here.
As always, we welcome your feedback, perspectives, and opportunities for collaboration as we continue advancing bio-hybrid innovation together.
This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No. 101070328.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Commission. Neither the European Union nor the granting authority can be held responsible for them.